Menu Search
Equities

Fangzhou Inc

6086:HKG

Fangzhou Inc

Actions
Health CareHealth Care Providers
  • Price (HKD)5.83
  • Today's Change-0.81 / -12.20%
  • Shares traded785.50k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 08:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Fangzhou Inc grew revenues 10.43% from 2.20bn to 2.43bn. Additionally the company has reduced the cost of goods sold, selling, general and administrative expenses and debt expenses (all as percentages of sales). These changes narrowed profitability losses from -383.30m to -196.79m.
Gross margin20.52%
Net profit margin-34.94%
Operating margin-29.09%
Return on assets--
Return on equity--
Return on investment--
More ▼

Cash flow in CNYView more

In 2023, Fangzhou Inc increased its cash reserves by 8.46%, or 11.41m. The company earned 22.28m from its operations for a Cash Flow Margin of 0.92%. In addition the company generated 16.42m cash from investing, though they paid out 29.31m more in financing than they received.
Cash flow per share-0.6731
Price/Cash flow per share--
Book value per share-1.60
Tangible book value per share-1.60
More ▼

Balance sheet in CNYView more

Fangzhou Inc appears to have a weak balance sheet, highlighted by its negative owner's equity. Additionally, this company's debt load outweighs its assets and with an Interest Coverage ratio of only 0.054180000000000, earnings from day-to-day operations are not enough to service its debt.
Current ratio0.9626
Quick ratio0.699
Total debt/total equity--
Total debt/total capital30.75
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.